Role of fibronectin in vascular plexus self-organization during embryogenesis

纤连蛋白在胚胎发生过程中血管丛自组织中的作用

基本信息

  • 批准号:
    7582334
  • 负责人:
  • 金额:
    $ 25.73万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-02-01 至 2012-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Vessel formation from mesodermal progenitors, vasculogenesis, is a fundamental process common to both embryonic development and certain pathophysiologies. Recently we showed that the formation of vascular cords from isolated clusters of angioblasts involves extensive invasive activity. During this process, vasculogenic sprouting, a group of endothelial cells invades hundreds of micrometers into avascular areas, and thereby lays down the structure of the primordial vascular plexus. We aim to determine the specific role of fibronectin, and its major endothelial receptors in the process. Specifically, we will (1) determine if fibronectin acts as a guidance cue during vasculogenic sprouting, (2) study the cell-mediated macro- assembly dynamics and turnover of the transient, fibronectin-rich extracellular matrix surrounding the cords of primordial endothelial cells, (3) determine the molecular composition of cell adhesion complexes and the respective roles of integrins avb3 and a5b1, and (4) synthesize the experimental data into a quantitative model of vasculogenesis. Vasculogenic sprouting will be studied in vivo, through automated optical microscopy and a combination of fluorescence-tagged antibodies and GFP constructs, in the presence or absence of perturbing reagents. The long term goal of the project is to understand endothelial cell-ECM interactions in sufficient detail to allow the construction of predictive quantitative models, either for tissue engineering, or to understand developmental morphogenetic processes. Understanding blood vessel development is of overwhelming clinical importance. Our goal, and the goal of other vascular biologists, is to explain the mechanisms that promote or inhibit vessel growth and thus regulate the structure of the vessel network. In particular, endothelial progenitors are in the focus of therapeutic vascularization strategies, tissue engineering, and attempts to block tumor growth.
描述(由申请人提供):中胚层祖细胞的血管形成(血管发生)是胚胎发育和某些病理生理学共同的基本过程。最近,我们发现成血管细胞的血管索的形成涉及广泛的侵入活动。在这个过程中,血管生成萌芽,一组内皮细胞侵入数百微米的无血管区域,从而奠定了原始血管丛的结构。我们的目的是确定纤连蛋白的具体作用,其主要的内皮细胞受体的过程中。具体地说,我们将(1)确定纤连蛋白是否在血管生成出芽过程中作为指导线索,(2)研究细胞介导的短暂的、富含纤连蛋白的细胞外基质在原始内皮细胞索周围的宏观组装动力学和周转,(3)确定细胞粘附复合物的分子组成以及整合素avb 3和a5 b 1的各自作用,(4)将实验数据综合成血管发生的定量模型。血管生成发芽将在体内进行研究,通过自动光学显微镜和荧光标记的抗体和GFP构建体的组合,在存在或不存在干扰试剂。该项目的长期目标是充分详细地了解内皮细胞-ECM相互作用,以构建预测性定量模型,用于组织工程或了解发育形态发生过程。 了解血管发育具有压倒性的临床重要性。我们的目标和其他血管生物学家的目标是解释促进或抑制血管生长的机制,从而调节血管网络的结构。特别地,内皮祖细胞是治疗性血管化策略、组织工程和阻断肿瘤生长的尝试的焦点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANDRAS CZIROK其他文献

ANDRAS CZIROK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANDRAS CZIROK', 18)}}的其他基金

Role of SPECC1L cytoskeletal protein in palate elevation dynamics
SPECC1L 细胞骨架蛋白在上颚抬高动态中的作用
  • 批准号:
    10638817
  • 财政年份:
    2023
  • 资助金额:
    $ 25.73万
  • 项目类别:
Morphogenetic Tissue Movements in Early Embryos
早期胚胎中的形态发生组织运动
  • 批准号:
    8921214
  • 财政年份:
    2014
  • 资助金额:
    $ 25.73万
  • 项目类别:
Morphogenetic Tissue Movements in Early Embryos
早期胚胎的形态发生组织运动
  • 批准号:
    8547954
  • 财政年份:
    2014
  • 资助金额:
    $ 25.73万
  • 项目类别:
Morphogenetic Tissue Movements in Early Embryos
早期胚胎的形态发生组织运动
  • 批准号:
    9119848
  • 财政年份:
    2014
  • 资助金额:
    $ 25.73万
  • 项目类别:
Role of fibronectin in vascular plexus self-organization during embryogenesis
纤连蛋白在胚胎发生过程中血管丛自组织中的作用
  • 批准号:
    7763819
  • 财政年份:
    2007
  • 资助金额:
    $ 25.73万
  • 项目类别:
Role of fibronectin in vascular plexus self-organization during embryogenesis
纤连蛋白在胚胎发生过程中血管丛自组织中的作用
  • 批准号:
    7190786
  • 财政年份:
    2007
  • 资助金额:
    $ 25.73万
  • 项目类别:
Role of fibronectin in vascular plexus self-organization during embryogenesis
纤连蛋白在胚胎发生过程中血管丛自组织中的作用
  • 批准号:
    7341118
  • 财政年份:
    2007
  • 资助金额:
    $ 25.73万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 25.73万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 25.73万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 25.73万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.73万
  • 项目类别:
    Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 25.73万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 25.73万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 25.73万
  • 项目类别:
    Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 25.73万
  • 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
  • 批准号:
    10491642
  • 财政年份:
    2023
  • 资助金额:
    $ 25.73万
  • 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
  • 批准号:
    10782567
  • 财政年份:
    2023
  • 资助金额:
    $ 25.73万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了